TG THERAPEUTICS, INC. (TGTX) › Shares OutstandingTG THERAPEUTICS, INC. (TGTX) — Shares OutstandingAnnual figures by period end, from SEC filings.2011-12-31: 5.06M2012-12-31: 25.81M2013-12-31: 34.29M2014-12-31: 44.93M2015-12-31: 54.05M2016-12-31: 56.78M2017-12-31: 73.14M2018-12-31: 83.87M2019-12-31: 109.38M2020-12-31: 140.58M2021-12-31: 143.25M2022-12-31: 146.39M2023-12-31: 151.42M2024-12-31: 155.84M2025-12-31: 155.31M155.31M2011-12-31Shares Outstanding (shares)2025-12-31Period endedShares OutstandingChange YoYSource filing2025-12-31155.31M-0.3%2026-02-27Balance as of period end2024-12-31155.84M+2.9%2026-02-27Balance as of period end2023-12-31151.42M+3.4%2025-03-03Balance as of period end2022-12-31146.39M+2.2%2024-02-29Balance as of period end2021-12-31143.25M+1.9%2023-03-01Balance as of period end2020-12-31140.58M+28.5%2022-03-01Balance as of period end2019-12-31109.38M+30.4%2021-03-01Balance as of period end2018-12-3183.87M+14.7%2020-03-02Balance as of period end2017-12-3173.14M+28.8%2019-03-01Balance as of period end2016-12-3156.78M+5.0%2018-03-15Balance as of period end2015-12-3154.05M+20.3%2017-03-16Balance as of period end2014-12-3144.93M+31.0%2016-03-15Balance as of period end2013-12-3134.29M+32.9%2015-03-16Balance as of period end2012-12-3125.81M+409.9%2014-03-07Balance as of period end2011-12-315.06M—2013-03-21Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)